Insilico Medicine, a clinical-stage biotechnology company specializing in generative AI-driven drug discovery, has announced that its novel compound, ISM6331, has …
Recursion Pharmaceuticals, a biotech firm leveraging artificial intelligence (AI) for drug discovery, has announced its acquisition of Exscientia, a smaller …
Brain-computer interface (BCI) technologies are rapidly becoming the spotlight of the neurotech industry, with Neuralink at the forefront. Recently, Neuralink …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.